Promoting Informed Choice for Breast Cancer Screening

Part of paid clinical trials in Aurora, Colorado.

Sponsor
University of Colorado, Denver
Study ID
NCT05376241
Phase
PHASE2
Status
Completed

Conditions

Eligibility Criteria

Sex
FEMALE
Age
39 Years - 49 Years
Healthy Volunteers
Not accepted

Interventions

  • Decision aid — BEHAVIORAL
    Mammography screening decision aid for women in their 40s with information about screening guidelines, breast cancer mortality reduction, false positives, overdiagnosis, and a personal breast cancer risk estimate.

Study Details

Identify the prevalence and predictors of reactance, self-exemption, disbelief, source derogation in reaction to evidence about mammography benefits and harms, and consequences for decision-making and trust.

Key Dates

Start date
Jan 3, 2022
Status verified
Mar 2026
Primary completion
May 7, 2022
Completion
May 7, 2022

Study Design

Enrollment
637 participants (actual)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH

Arms

  • Experimental: Women age 39-49 in the United States
    The group is women age 39-49 in the United States who receive a decision aid intervention. The intervention is a breast cancer screening decision aid with information about screening guidelines, breast cancer mortality reduction, false positives, overdiagnosis, and a personal breast cancer risk estimate.

Primary Outcome Measure

Reactance [ Time Frame: 24 hours ]

Locations (1)

FacilityCityStateZIP
University of Colorado Anschutz Medical CampusAuroraColorado80045

Find similar trials in Aurora, CO

By condition
Breast cancer
By specialty
OncologyBreast oncologyWomen's health
By research site
University of Colorado Anschutz Medical Campus· Aurora, CO

Related Studies